CRISPR Trial Provides Hope for Inherited Blindness
A recent clinical trial, BRILLIANCE demonstrated the safety and efficacy of CRISPR gene editing in treating inherited blindness caused by mutations in the CEP290 gene.
Source: neurosciencenews.com
Stay updated with breaking news from Ryan Jaslow. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A recent clinical trial, BRILLIANCE demonstrated the safety and efficacy of CRISPR gene editing in treating inherited blindness caused by mutations in the CEP290 gene.
A mix-up with a passenger's mother calling a hospital to ask advice for daughter's rash treatment led to Delta flight investigation from health officials